EMTA-AHP 500mg injection

EMTA-AHP 500mg Injection contains Pemetrexed 500mg, an anticancer medicine belonging to the antimetabolite chemotherapy class. It is marketed by Al Habib Pharmaceuticals (AHP) in Pakistan. Al Habib Pharmaceuticals identifies AHP EMTA as a Pemetrexed 500mg injection and describes it as an oncology product. Pemetrexed works by interfering with several enzymes involved in the production of DNA and RNA, which are essential for cancer-cell growth and multiplication. It is commonly used as part of chemotherapy regimens for non-small-cell lung cancer (NSCLC) and malignant pleural mesothelioma, depending on the patient's diagnosis and treatment protocol. It may be administered alone or in combination with other anticancer medicines. EMTA-AHP is administered by intravenous infusion under the supervision of an oncologist or qualified healthcare professional. The dose and treatment schedule depend on the type of cancer, body surface area, kidney function, and the prescribed chemotherapy regimen. Common side effects may include fatigue, nausea, vomiting, loss of appetite, diarrhea, mouth sores, rash, and reduced blood-cell counts. Patients receiving pemetrexed may require regular blood tests and supportive supplementation such as folic acid and vitamin B12 according to the oncology protocol.

Price: Rs. 79700.00

• Manufacturer
  Al Habib Pharmaceutical
• Generic name
  Pemetrexed
• Pack size
  1 Vial injection
• Availability
  In stock
• Prescription required
  Yes